January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Proterris, Inc
Proterris is clinical-stage, global leader in carbon monoxide therapeutics, having far greater clinical and market potential than nitric oxide or other "gasotransmitters" such as xenon or hydrogen sulfide.